Trump’s Iran Provoked Senate Sparks War-Powers Debate
The Senate backed a symbolic war-powers resolution in a tight 50-48 vote, signaling bipartisan unease with Trump-era ...
Financial News — Page 145
Godmother AI: Tech Entrepreneurs Pivot to World Models
Investors are pouring capital into a new class of AI startups focused on world models, a movement led by tech founder...
Chemours to Pay About $450 Million in PFAS Settlement
The Justice Department announced a multi-state PFAS settlement with Chemours, totaling about $450 million in penaltie...
From Recovery Real Estate: Tracy Jones Team Tops Ohio Market
A Northeast Ohio real estate team built on disciplined systems rises to No. 1 in Ohio among medium teams for 2025, wi...
Checklist Real Estate Agents Need for Estate Sales Timing
Aging homeowners are turning estate sales into a routine part of listings, prompting a need for a formal checklist re...
SNPD Targets Next Dividend Aristocrats with 10-Year Growth
The SNPD ETF is widening its search for dividend growth by applying a 10-year growth screen to identify the next gene...
Legally Protected Financial Monopoly at Center Stage
A dominant market infrastructure firm sits at the heart of capital markets, wielding a legally protected financial mo...
Forget CrowdStrike. 0.59% This Fund Owns It Plus Rivals
A diversified cybersecurity ETF now holds CrowdStrike alongside 30 other rivals, offering broad exposure as AI-driven...
Coinbase Could Jump Higher as Crypto Recovery Unfolds
A broad crypto rebound is lifting Coinbase as the company pivots toward subscriptions and services. Analysts see upsi...
FHFA Pushes GSEs Embrace Chattel Loans in DTS Overhaul
The FHFA proposes an outcome-based Duty to Serve overhaul to push Fannie Mae and Freddie Mac toward stronger support ...
Road Work Ahead: Loans Brace for New Housing Policy Push in Markets
A major housing policy overhaul is poised to reshape mortgage lending as banks recalibrate underwriting and borrowers...
Can’t Stop Buying This Dividend Juggernaut: ABBV Growth
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...